Suppr超能文献

人类巨细胞病毒和单纯疱疹病毒I型可利用RNA聚合酶I转录立即早期基因。

Human cytomegalovirus and Herpes Simplex type I virus can engage RNA polymerase I for transcription of immediate early genes.

作者信息

Kostopoulou Ourania N, Wilhelmi Vanessa, Raiss Sina, Ananthaseshan Sharan, Lindström Mikael S, Bartek Jiri, Söderberg-Naucler Cecilia

机构信息

Department of Medicine, Center for Molecular Medicine L8:03, Karolinska University Hospital, Stockholm, Sweden.

Department of Medical Biochemistry and Biophysics, Science For Life Laboratory, Division of Genome Biology, Karolinska Institute, Solna, Sweden.

出版信息

Oncotarget. 2017 Oct 29;8(57):96536-96552. doi: 10.18632/oncotarget.22106. eCollection 2017 Nov 14.

Abstract

Human cytomegalovirus (HCMV) utilizes RNA polymerase II to transcribe viral genes and produce viral mRNAs. It can specifically target the nucleolus to facilitate viral transcription and translation. As RNA polymerase I (Pol I)-mediated transcription is active in the nucleolus, we investigated the role of Pol I, along with relative contributions of the human Pol II and Pol III, to early phases of viral transcription in HCMV infected cells, compared with Herpes Simplex Virus-1 (HSV-1) and Murine cytomegalovirus (MCMV). Inhibition of Pol I with siRNA or the Pol I inhibitors CX-5461 or Actinomycin D (5nM) resulted in significantly decreased IE and pp65 mRNA and protein levels in human fibroblasts at early times post infection. This initially delayed replication was compensated for later during the replication process, at which stage it didn't significantly affect virus production. Pol I inhibition also reduced HSV-1 ICP0 and gB transcripts, suggesting that some herpesviruses engage Pol I for their early transcription. In contrast, inhibition of Pol I failed to affect MCMV transcription. Collectively, our results contribute to better understanding of the functional interplay between RNA Pol I-mediated nucleolar events and the Herpes viruses, particularly HCMV whose pathogenic impact ranges from congenital malformations and potentially deadly infections among immunosuppressed patients, up to HCMV's emerging oncomodulatory role in human tumors.

摘要

人巨细胞病毒(HCMV)利用RNA聚合酶II转录病毒基因并产生病毒mRNA。它可以特异性靶向核仁以促进病毒转录和翻译。由于RNA聚合酶I(Pol I)介导的转录在核仁中活跃,我们研究了Pol I以及人Pol II和Pol III的相对贡献,与单纯疱疹病毒1型(HSV-1)和鼠巨细胞病毒(MCMV)相比,在HCMV感染细胞中病毒转录早期阶段的作用。用小干扰RNA(siRNA)或Pol I抑制剂CX-5461或放线菌素D(5nM)抑制Pol I导致感染后早期人成纤维细胞中IE和pp65 mRNA及蛋白水平显著降低。这种最初延迟的复制在复制过程后期得到补偿,在此阶段它对病毒产生没有显著影响。Pol I抑制也降低了HSV-1 ICP0和gB转录本,表明一些疱疹病毒利用Pol I进行早期转录。相比之下,抑制Pol I未能影响MCMV转录。总的来说,我们的结果有助于更好地理解RNA Pol I介导的核仁事件与疱疹病毒之间的功能相互作用,特别是HCMV,其致病影响范围从先天性畸形和免疫抑制患者中潜在的致命感染,到HCMV在人类肿瘤中新兴的肿瘤调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfe7/5722503/ad6c5a4664cd/oncotarget-08-96536-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验